Group 1 - The company Donghu Gaoxin announced that as of September 23, 2025, the total external guarantees provided by the company and its subsidiaries amount to approximately 6.68 billion yuan, which represents 75.4% of the audited equity attributable to the parent company's owners for the most recent fiscal year [1] - Among the total guarantees, the actual balance of guarantees provided by the company for its wholly-owned, controlling subsidiaries, and subsidiaries for their sub-subsidiaries is approximately 1.345 billion yuan, accounting for 15.18% of the audited equity attributable to the parent company's owners for the most recent fiscal year [1]

北京德恒（武汉）律师事务所 关于武汉东湖高新集团股份有限公司 2025 年第二次临时股东大会的 法律意见 武汉市洪山区欢乐大道 1 号德成国贸中心 B 座 26 层 邮编：430060 电话：(86)027-88615675 北京德恒（武汉）律师事务所 关于武汉东湖高新集团股份有限公司 2025 年第二次临时股东大会的法律意见 北京德恒（武汉）律师事务所 关于武汉东湖高新集团股份有限公司 2025 年第二次临时股东大会的 法律意见 2025 德恒汉法意 DHWH067 号 致：武汉东湖高新集团股份有限公司 武汉东湖高新集团股份有限公司（以下简称"公司"）2025 年第二次临时股 东大会（以下简称"本次会议"）于 2025 年 9 月 22 日（星期一）召开。北京德 恒（武汉）律师事务所（以下简称"德恒"）受公司委托，指派本所经办律师（以 下简称"德恒律师"）出席了本次会议。根据《中华人民共和国证券法》（以下 简称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、 中国证券监督管理委员会《上市公司股东会规则》（以下简称"《股东会规则》"）、 《武汉东湖高新集团股份有限公司章程》（以下简称"《 ...

(一)股东大会召开的时间：2025 年 9 月 22 日 证券代码：600133 证券简称：东湖高新 公告编号：临 2025-068 武汉东湖高新集团股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (五)公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 (二)股东大会召开的地点：湖北省武汉市东湖新技术开发区花城大道 9 号武汉软 件新城 1.1 期 A8 栋 A 座一楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 1,018 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 260,174,372 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 24.4011 | | 份总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会 ...

证券代码：600133 证券简称：东湖高新 2025 年第二次临时股东大会会议资料 武汉东湖高新集团股份有限公司 2025 年第二次临时股东大会 会 议 资 料 二○二五年九月二十二日 1 证券代码：600133 证券简称：东湖高新 2025 年第二次临时股东大会会议资料 武汉东湖高新集团股份有限公司 2025 年第二次临时股东大会会议资料 武汉东湖高新集团股份有限公司（以下简称"公司"） 2025年第二次临时股东 大会会议安排如下： 一、会议安排 （一）现场会议时间：2025 年 9 月 22 日（星期一）下午 14 点 00 分 （二）网络投票时间：2025 年 9 月 22 日（星期一） 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东 大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联 网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （三）现场会议地点：湖北省武汉市东湖新技术开发区花城大道 9 号武汉软件 新城 1.1 期 A8 栋 A 座一楼会议室 （3）关于修订《武汉东湖高新集团股份有限公司股东会议事规则》 ...

Core Viewpoint - The company has signed a guarantee contract with Agricultural Bank of China for a loan of RMB 600 million for its wholly-owned subsidiary, Wuhan Donghu Gaoxin Pharmaceutical Investment Co., Ltd, indicating a strategic move to support its subsidiary's financing needs [2][4]. Group 1: Guarantee Overview - The company will provide a guarantee of RMB 600 million for the loan applied by its subsidiary, with no outstanding balance prior to this guarantee [2][3]. - As of September 10, 2025, the total actual guarantee amount provided by the company to its wholly-owned and controlling subsidiaries is RMB 1.267 billion, while guarantees to associated companies amount to RMB 1.038 million [3][12]. Group 2: Internal Decision-Making Process - The company's board of directors approved the 2025 annual guarantee plan, allowing for a total guarantee amount of up to RMB 6.125 billion for its subsidiaries, with specific limits based on their debt-to-asset ratios [4][10]. - The shareholders' meeting on June 5, 2025, ratified the 2025 annual guarantee plan [4]. Group 3: Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary to alleviate financial pressure for project construction and to meet operational needs [9]. - The guarantee does not constitute a related party transaction and is expected to have no adverse impact on the company's interests or operational independence [4][9]. Group 4: Board's Opinion - The board believes that the subsidiaries have repayment capabilities and that the guarantee will not harm the company's interests, thus supporting the decision to proceed with the guarantee [10].

Core Viewpoint - Wuhan Donghu Gaoxin Group Co., Ltd. has provided a guarantee for its wholly-owned subsidiary, Wuhan Donghu Gaoxin Pharmaceutical Investment Co., Ltd., for a loan of RMB 600 million from Agricultural Bank of China [2][5] Summary by Sections Guarantee Details - The guarantee amount is RMB 600 million, and the total amount guaranteed for Donghu Pharmaceutical Investment is also RMB 600 million as of the announcement date [3][4] - There is no counter-guarantee involved in this transaction [4] Financial Context - As of September 10, 2025, the company has provided actual guarantees totaling RMB 1.267 billion for its wholly-owned and controlling subsidiaries, and RMB 10.38 million for its affiliated companies [4][15] - The total amount of external guarantees provided by the company and its controlling subsidiaries is RMB 6.703 billion, which accounts for 75.66% of the audited equity attributable to the parent company for the most recent fiscal year [15] Internal Decision-Making Process - The company's board of directors approved the annual guarantee plan for 2025 on April 25, 2025, allowing for a total guarantee amount not exceeding RMB 6.125 billion for its wholly-owned and controlling subsidiaries [6][14] - The shareholders' meeting on June 5, 2025, ratified the 2025 annual guarantee plan [8] Necessity and Reasonableness of the Guarantee - The guarantee is intended to alleviate financial pressure for project construction and meet operational needs [13] - The guarantee does not constitute a related party transaction and will not harm the interests of the company and its shareholders [5][13] Board of Directors' Opinion - The board believes that the subsidiaries have the ability to repay the loans and that the guarantee will not harm the company's interests [14][15]

Core Points - Donghu Gaoxin announced the signing of a guarantee contract with Agricultural Bank of China Wuhan Wuchang Branch for a loan application of RMB 600 million by its wholly-owned subsidiary, Wuhan Donghu Gaoxin Pharmaceutical Investment Co., Ltd. [1] - The total amount of external guarantees provided by the company and its subsidiaries as of September 10, 2025, is RMB 670.33 million, which accounts for 75.66% of the audited equity attributable to the parent company's owners for the most recent fiscal year. [1]

证券代码：600133 证券简称：东湖高新 公告编号：临 2025-067 武汉东湖高新集团股份有限公司 关于为全资子公司武汉东湖高新医药投资有限公司 提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 本次担保本金金额 | 60,000.00 | 武汉东湖高新医药投资有限公司 万元 | | | --- | --- | --- | --- | --- | | 担保对象 | 实际为其提供的担保余额 | 0 万元 | | | | | 是否在前期预计额度内 | 是 □否 | | □不适用：_________ | | | 本次担保是否有反担保 | 是 ☑否 | | □不适用：_________ | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 127,829.28（担保实际发生余额） | | | 670,329.28（包含担保实际发生余额与已批 | | ...

长江商报消息 ●长江商报记者 李璟 谋求新发展，东湖高新（600133.SH）加速业务优化与转型升级。 东湖高新日前发布公告，公司拟参与设立"咸宁东高产业投资基金合伙企业（有限合伙）"（简称"咸宁 东高基金"），基金规模为5亿元，其中公司认缴出资2亿元。 根据东湖高新公告，公司拟与全资子公司东湖投资、咸宁高新资本运营有限公司（简称"咸宁资本"）、 咸宁高新产业发展有限公司（简称"咸宁产业"）共同发起设立"咸宁东高产业投资基金合伙企业（有限 合伙）"（暂定名，最终名称以市场监督管理局核准登记名称为准）。 咸宁东高基金规模为5亿元，东湖高新认缴出资2亿元，作为有限合伙人，占基金规模的40%；公司全资 子公司东湖投资认缴出资5000万元，作为基金普通合伙人，占基金规模的10%；咸宁资本和咸宁产业分 别认缴出资1.25亿元，作为有限合伙人，各占基金规模的25%。出资方式均为货币出资。 从基金投资领域来看，咸宁东高基金将重点投资新材料、先进制造、大健康、生物医药、电子信息等领 域的优质企业。 东湖高新在公告中指出，公司此次出资设立咸宁东高基金，是加快公司科技园板块转型发展的重要举 措，通过基金形式开展产业投资，能够提升 ...

Key Points - Western Gold's main business includes gold mining and smelting [1] - Donghu Gaoxin's subsidiary plans to establish a joint venture for the Changzi waste incineration project [1] - Southeast Network Framework won a 1.32 billion yuan EPC project as part of a consortium [1] - New Fengming intends to acquire 100% of Samir for 102 million yuan [1] - Lingzhi Software completed the second phase of share repurchase, totaling 0.9375% of its shares [1][2] - New Hope reported 1.722 billion yuan in pig sales revenue for August [1][2] - Muyuan Foods reported 11.85 billion yuan in pig sales revenue for August [1][2] - Shareholders of Chengda Street Industry plan to reduce their holdings by no more than 7.27% [1][3] - ST Lingnan received a notice from the Securities Regulatory Commission regarding suspected information disclosure violations [1][3]